Evidence map›Paper›PMID 38505601›Full record

ArticleTheranostics2024

Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy

Aimin Wu, Ming Han, Zihan Ni, Haoran Li, Yinyin Chen, Zhouping Yang, Yumei Feng, Zufeng He, Hua Zhen, Xianxiang Wang

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. CuOMikrochimica acta · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Aimin WuInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Ming HanCollege of Science, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Zihan NiCollege Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Haoran LiCollege of Agronomy, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Yinyin ChenCollege of Agronomy, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Zhouping YangInstitute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Yumei FengState Key Laboratory of Crop Gene Exploration and Utilization in Southwest China, Chengdu 611130, Sichuan, China.
Zufeng HeInstitute of New Rural Development, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Hua ZhenCollege of Science, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Xianxiang WangCollege of Science, Sichuan Agricultural University, Chengdu 611130, Sichuan, China.
Sichuan Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FerroptosisNeoplasmsRegulated Cell DeathAnimalsApoptosisCell Line, TumorDoxorubicinDrug Delivery SystemsGlutathioneGlutathione DisulfideOxidoreductasesTumor MicroenvironmentDoxorubicinGlutathioneGlutathione DisulfideOxidoreductasesApoptosisDoxorubicinFerroptosisTumor therapyZIF-8/SrSe

Identifiers

PMID38505601
PMCPMC10945335
OpenAlexW4392830672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.